ORRU', MARISA MARGHERITA
 Distribuzione geografica
Continente #
EU - Europa 33.338
NA - Nord America 1.746
AS - Asia 248
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 35.341
Nazione #
IT - Italia 32.812
US - Stati Uniti d'America 1.727
CN - Cina 207
UA - Ucraina 191
SE - Svezia 164
FI - Finlandia 55
DE - Germania 50
GB - Regno Unito 33
SG - Singapore 33
CA - Canada 19
FR - Francia 18
AU - Australia 4
BE - Belgio 4
EU - Europa 3
KR - Corea 3
NL - Olanda 3
BD - Bangladesh 2
CH - Svizzera 2
PL - Polonia 2
RU - Federazione Russa 2
BR - Brasile 1
IE - Irlanda 1
IN - India 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
TR - Turchia 1
Totale 35.341
Città #
Cagliari 32.532
Fairfield 270
Woodbridge 175
Wilmington 135
Chandler 130
Houston 117
Nyköping 116
Ashburn 110
Ann Arbor 108
Seattle 108
Jacksonville 104
Cambridge 92
Dearborn 73
Beijing 41
Nanjing 41
Boardman 26
Shanghai 24
Boston 23
Helsinki 23
San Diego 17
Toronto 14
Treviso 14
Los Angeles 13
Milan 12
Molise 11
Singapore 11
Shenyang 9
Jiaxing 8
Tianjin 8
Changsha 7
Hebei 7
Hefei 7
Settimo Torinese 6
Guangzhou 5
Mountain View 5
Norwalk 5
Redwood City 5
Rome 5
Brussels 4
Falls Church 4
Jinan 4
Kilburn 4
Kunming 4
Nanchang 4
New York 4
Orange 4
Palermo 4
Verona 4
Alcamo 3
Alghero 3
Auburn Hills 3
Mogliano Veneto 3
Sassari 3
Taizhou 3
Frosinone 2
Gimigliano 2
Hounslow 2
London 2
Messina 2
Monserrato 2
Naples 2
Ningbo 2
Padova 2
Pieve 2
Ponte Buggianese 2
Rimini 2
San Felice Sul Panaro 2
San Germano Vercellese 2
Santa Venerina 2
Segrate 2
Torino 2
Villeparisis 2
Washington 2
Wuhan 2
Yiwu 2
Zhengzhou 2
Acton 1
Arzano 1
Bastia 1
Belleville 1
Bologna 1
Brescia 1
Caiazzo 1
Carmagnola 1
Cesena 1
Chaoyang 1
Chongqing 1
Cogorno 1
Condé-sur-huisne 1
Corona 1
Council Bluffs 1
Dallas 1
Delft 1
Fano 1
Ferrara 1
Foligno 1
Forlì 1
Genova 1
Genzano di Roma 1
Hangzhou 1
Totale 34.543
Nome #
Overview of elagolix for the treatment of endometriosis 3.153
Vaginosi batterica: efficacia di un trattamento locale con un gel vaginale a base di una frazione batterica derivata da Propionibacterium acnes 2.697
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.302
Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report 1.628
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol 1.594
Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. 1.424
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 1.333
Low androgenization index in elderly women and elderly men with Alzheimer's disease 1.241
Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy 1.232
The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study 1.186
Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass 1.166
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol: observational study in young postadolescent women 1.164
Pattern of bone markers during pregnancy and their changes after delivery. 1.156
Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women 1.079
The treatment of polycystic ovary syndrome 1.061
Correlazioni tra composizione corporea ed età 1.030
Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women 1.004
La scelta razionale: terapia ormonale a basso dosaggio 975
The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome 860
null 814
Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel. 762
Contraccezione estroprogestinica dopo il 2000. L'utilizzazione dei bassissimi dosaggi 755
Hyperinsulinemia and uterine perfusion in patients with polycystic ovary syndrome 740
Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies 606
Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic-ovary-syndrome 568
Evidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopause 562
The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome 559
Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy 543
Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome 528
Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women 518
Melatonin enhances the luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the follicular, but not in the luteal, menstrual phase 510
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism 503
Chorioamnionitis 131
Totale 35.384
Categoria #
all - tutte 43.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019151 0 0 0 0 0 0 0 0 0 0 0 151
2019/20209.922 553 260 42 126 4.374 2.435 1.332 259 114 86 147 194
2020/20219.811 244 306 274 3.604 2.383 925 674 441 195 284 318 163
2021/20222.099 153 215 78 108 209 262 180 63 100 171 315 245
2022/20231.978 264 203 223 157 219 221 82 166 125 91 152 75
2023/20242.406 129 101 141 188 250 389 403 174 94 183 204 150
Totale 35.384